- The eight patents in the case relate to ways to analyze cells to identify antibodies that can be used to prevent and treat diseases
- AbCellera said its technology was used to discover the first antibody against Covid-19
Eli Lillyis workingwith closely held AbCellera in the development of so-called “neutralizing” antibodies that are tailored to mimic immune responses to the virus
- Berkeley Light’s Beacon Optofluidic System, used ...
July 10, 2020, 4:47 PM
Berkeley Lights Sued by AbCellera on Antibody Test Patents